subscribeSubscribe
Dr. Reddy`s Labs partners with Bayer for second brand of Vericiguat for India market

Dr. Reddy`s Labs partners with Bayer for second brand of Vericiguat for India market
BUSINESS STANDARD
06 Apr 2024
Share Share
Heart disease needs a new drug – Vericiguat

Heart disease needs a new drug – Vericiguat
PRESS RELEASE
09 Feb 2022
Share Share
Merck commences Phase III trial of Verquvo for heart failure

Merck commences Phase III trial of Verquvo for heart failure
CLINICALTRIALSARENA
13 Nov 2021
Share Share
Merck Begins Phase 3 Study of VERQUVO in CHF and Reduced Ejection Fraction

Merck Begins Phase 3 Study of VERQUVO in CHF and Reduced Ejection Fraction
BUSINESSWIRE
11 Nov 2021
Share Share
Bayer`s Verquvo (vericiguat) Receives Approval in Europe

Bayer`s Verquvo (vericiguat) Receives Approval in Europe
EMA
16 Jul 2021
Share Share
US approval for MSD’s heart failure med Verquvo

US approval for MSD’s heart failure med Verquvo
Lucy Parsons PHARMATIMES
21 Jan 2021
Share Share
Merck, Bayer win FDA approval for heart failure drug

Merck, Bayer win FDA approval for heart failure drug
Kristin Jensen BIOPHARMADIVE
21 Jan 2021
Share Share
Merck, Bayer`s new Verquvo faces tough heart failure market

Merck, Bayer`s new Verquvo faces tough heart failure market
Angus Liu FIERCEPHARMA
20 Jan 2021
Share Share
Bayer submits vericiguat for marketing authorization in China for the treatment

Bayer submits vericiguat for marketing authorization in China for the treatment
PHARMASHOTS
28 Aug 2020
Share Share
FDA puts Merck`s heart failure drug on priority review track

FDA puts Merck`s heart failure drug on priority review track
Nick Paul Taylor FIERCEBIOTECH
17 Jul 2020
Share Share